India battles worst of Covid-19 as worry about paediatric illness looms Pharmacists are warning of a shortage of a crucial drug to treat an invasive fungal infection preying on patients with weakened immune systems 21 May 2021 - 09:51 Bhuma Shrivastava, Jason Gale and Chris Kay Amphotericin B antifungal drug molecule. Skeletal formula. Picture: 123RF/molekuul
Mumbai/Melbourne/London Rare, life-threatening Covid-19 complications appear to be escalating in India, creating a new wave of critical medical challenges in a country that has already seen short supplies of oxygen and other basic needs.
Pharmacists are warning of a shortage of a crucial drug to treat an invasive fungal infection preying on patients with weakened immune systems and diabetes. An uptick in cases across India of a dangerous inflammatory syndrome in children also seen in the US and Europe at the height of their outbreaks is a harbinger of a potentially deadly spate of the pediatric
Cascade of rare complications deepen India s coronavirus misery
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Fungal epidemic, sick babies deepen India s COVID-19 misery
gulfnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gulfnews.com Daily Mail and Mail on Sunday newspapers.
Rare, Life-Threatening Covid Complications Cause Worry In India Rare, Life-Threatening Covid Complications Cause Worry In India Pharmacists are warning of a shortage of a crucial drug to treat an invasive fungal infection preying on patients with weakened immune systems.
Updated: May 20, 2021 5:44 pm IST
India has reported more than 25 million Covid cases, with half occurring in the past two months alone.
Rare, life-threatening Covid-19 complications appear to be escalating in India, creating a fresh wave of critical medical challenges in a country that has already seen short supplies of oxygen and other basic needs.
Pharmacists are warning of a shortage of a crucial drug to treat an invasive fungal infection preying on patients with weakened immune systems. An uptick in cases across India of a dangerous inflammatory syndrome in children also seen in the U.S. and Europe at the height of their outbreaks is a harbinger of a potentially deadly spate of the pediatric illnes